Literature DB >> 20134424

Synchronous infection of SIV and HIV in vitro for virology, immunology and vaccine-related studies.

Jonah B Sacha1, David I Watkins.   

Abstract

The development of an HIV vaccine will require a more precise understanding of the immunological and virological underpinnings of HIV infection. Magnetofection, the process of magnetizing HIV by coupling it to ferrous nanoparticles and coordinating infection using a magnetic field, synchronizes the viral replication cycle at attachment while recapitulating the events of natural infection. Although spinoculation also concentrates virus onto target cells to increase infection, it does not synchronize infection. The synchronization of HIV infection in vitro facilitates the study of events in the viral replication cycle and the antiviral immune response on timelines previously impossible. Furthermore, by infecting a high percentage of cells in a short time frame, magnetofection increases the throughput of in vitro assays. Once a virus stock is generated, magnetofection of target cells is rapid, requiring only 1-2 h. Here we present a detailed protocol for this assay and review its applications for studying the immune response to HIV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20134424      PMCID: PMC2936483          DOI: 10.1038/nprot.2009.227

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  18 in total

1.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Synchronized infection of cell cultures by magnetically controlled virus.

Authors:  Hillel Haim; Israel Steiner; Amos Panet
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression.

Authors:  Jonah B Sacha; Chungwon Chung; Eva G Rakasz; Sean P Spencer; Anna K Jonas; Alexander T Bean; Wonhee Lee; Benjamin J Burwitz; Jason J Stephany; John T Loffredo; David B Allison; Sama Adnan; Akihiko Hoji; Nancy A Wilson; Thomas C Friedrich; Jeffrey D Lifson; Otto O Yang; David I Watkins
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

4.  Efficient inhibition of SIV replication in rhesus CD4+ T-cell clones by autologous immortalized SIV-specific CD8+ T-cell clones.

Authors:  Jacob T Minang; Eugene V Barsov; Fang Yuan; Matthew T Trivett; Michael Piatak; Jeffrey D Lifson; David E Ott; Claes Ohlen
Journal:  Virology       Date:  2008-02-20       Impact factor: 3.616

5.  Isolation and propagation of HIV-1 on peripheral blood mononuclear cells.

Authors:  Angélique B van 't Wout; Hanneke Schuitemaker; Neeltje A Kootstra
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

6.  Differential antigen presentation kinetics of CD8+ T-cell epitopes derived from the same viral protein.

Authors:  Jonah B Sacha; Matthew R Reynolds; Matthew B Buechler; Chungwon Chung; Anna K Jonas; Lyle T Wallace; Andrea M Weiler; Wonhee Lee; Shari M Piaskowski; Taeko Soma; Thomas C Friedrich; Nancy A Wilson; David I Watkins
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

7.  Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection.

Authors:  Jonah B Sacha; Juan P Giraldo-Vela; Matthew B Buechler; Mauricio A Martins; Nicholas J Maness; Chungwon Chung; Lyle T Wallace; Enrique J León; Thomas C Friedrich; Nancy A Wilson; Atsunobu Hiraoka; David I Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-28       Impact factor: 11.205

8.  Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.

Authors:  Stephen A Migueles; Christine M Osborne; Cassandra Royce; Alex A Compton; Rohan P Joshi; Kristin A Weeks; Julia E Rood; Amy M Berkley; Jonah B Sacha; Nancy A Cogliano-Shutta; Margaret Lloyd; Gregg Roby; Richard Kwan; Mary McLaughlin; Sara Stallings; Catherine Rehm; Marie A O'Shea; JoAnn Mican; Beverly Z Packard; Akira Komoriya; Sarah Palmer; Ann P Wiegand; Frank Maldarelli; John M Coffin; John W Mellors; Claire W Hallahan; Dean A Follman; Mark Connors
Journal:  Immunity       Date:  2008-12-08       Impact factor: 31.745

9.  Nef-mediated MHC class I down-regulation unmasks clonal differences in virus suppression by SIV-specific CD8(+) T cells independent of IFN-gamma and CD107a responses.

Authors:  Jacob T Minang; Matthew T Trivett; Lori V Coren; Eugene V Barsov; Michael Piatak; David E Ott; Claes Ohlen
Journal:  Virology       Date:  2009-06-24       Impact factor: 3.616

10.  Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state.

Authors:  Hillel Haim; Zhihai Si; Navid Madani; Liping Wang; Joel R Courter; Amy Princiotto; Aemro Kassa; Marciella DeGrace; Kathleen McGee-Estrada; Megan Mefford; Dana Gabuzda; Amos B Smith; Joseph Sodroski
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

View more
  23 in total

1.  Magnetic nanoparticles enhance adenovirus transduction in vitro and in vivo.

Authors:  Cédric Sapet; Christophe Pellegrino; Nicolas Laurent; Flavie Sicard; Olivier Zelphati
Journal:  Pharm Res       Date:  2011-12-07       Impact factor: 4.200

2.  TCR triggering transcriptionally downregulates CCR5 expression on rhesus macaque CD4(+) T-cells with no measurable effect on susceptibility to SIV infection.

Authors:  Jacob T Minang; Matthew T Trivett; Eugene V Barsov; Gregory Q Del Prete; Charles M Trubey; James A Thomas; Robert J Gorelick; Michael Piatak; David E Ott; Claes Ohlen
Journal:  Virology       Date:  2010-10-28       Impact factor: 3.616

3.  Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection.

Authors:  Shokrollah Elahi; Toshiro Niki; Mitsuomi Hirashima; Helen Horton
Journal:  Blood       Date:  2012-03-21       Impact factor: 22.113

4.  Simian immunodeficiency virus-specific CD8+ T cells recognize Vpr- and Rev-derived epitopes early after infection.

Authors:  Jonah B Sacha; Matthew B Buechler; Laura P Newman; Jason Reed; Lyle T Wallace; John T Loffredo; Nancy A Wilson; David I Watkins
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

5.  Maintenance of AP-2-Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.

Authors:  Blake Schouest; Andrea M Weiler; Sanath Kumar Janaka; Tereance A Myers; Arpita Das; Sarah C Wilder; Jessica Furlott; Melody Baddoo; Erik K Flemington; Eva G Rakasz; David T Evans; Thomas C Friedrich; Nicholas J Maness
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

6.  Pharmacologic HIV-1 Nef blockade promotes CD8 T cell-mediated elimination of latently HIV-1-infected cells in vitro.

Authors:  Shariq Mujib; Aamir Saiyed; Saleh Fadel; Ardalan Bozorgzad; Nasra Aidarus; Feng Yun Yue; Erika Benko; Colin Kovacs; Lori A Emert-Sedlak; Thomas E Smithgall; Mario A Ostrowski
Journal:  JCI Insight       Date:  2017-09-07

7.  Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.

Authors:  Shariq Mujib; Jun Liu; A K M Nur-Ur Rahman; Jordan A Schwartz; Phil Bonner; Feng Yun Yue; Mario A Ostrowski
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

8.  Colony-Stimulating Factor 1 Receptor Antagonists Sensitize Human Immunodeficiency Virus Type 1-Infected Macrophages to TRAIL-Mediated Killing.

Authors:  Francesc Cunyat; Jennifer N Rainho; Brian West; Louise Swainson; Joseph M McCune; Mario Stevenson
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

9.  Pseudotyped murine leukemia virus for schistosome transgenesis: approaches, methods and perspectives.

Authors:  Victoria H Mann; Sutas Suttiprapa; Danielle E Skinner; Paul J Brindley; Gabriel Rinaldi
Journal:  Transgenic Res       Date:  2014-01-29       Impact factor: 2.788

10.  Multiparametric characterization of rare HIV-infected cells using an RNA-flow FISH technique.

Authors:  Amy E Baxter; Julia Niessl; Rémi Fromentin; Jonathan Richard; Filippos Porichis; Marta Massanella; Nathalie Brassard; Nirmin Alsahafi; Jean-Pierre Routy; Andrés Finzi; Nicolas Chomont; Daniel E Kaufmann
Journal:  Nat Protoc       Date:  2017-09-07       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.